Tenax Therapeutics
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
101 Glen Lennox Dr Unit 300, Chapel Hill...Phone Number
(919) 855-2100Website
www.tenaxthera.comRevenue
$10.6 MillionStock Symbol
TENXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Tenax Therapeutics
Tenax Therapeutics Inc. is a specialty pharmaceutical company. It focuses on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical needs, with an initial therapeutic focus on pulmonary hypertension. The company was founded in 1967 and is based in Chapel Hill, North Carolina.Explore more
Tenax Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tenax Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Tenax Therapeutics recently announced quarterly report
Check if Tenax Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Tenax Therapeutics
Funding: Get notified immidiatlly once Tenax Therapeutics has new funding data
Check out if Tenax Therapeutics is spiking on competitors!
Product Launch: Get notified when Tenax Therapeutics launches new products
Tenax Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Tenax Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Tenax Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Tenax Therapeutics
Compare insights from companies similar to Tenax Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Tenax Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tenax Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tenax Therapeutics.
Tenax Therapeutics financials insights
Gather financial insights about Tenax Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2024
Share Placement
$100M
Tenax Therapeutics Tech Stack
A closer look at the technologies used by Tenax Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Executive Moves, New Hire
Tenax Therapeutics News & Media
Tenax Therapeutics (TENX) Securities Investigation Notice - Levi & Korsinsky
Tenax Therapeutics shares fell approximately 84% to 85% after the Company disclosed that its Phase 3 LEVEL trial of TNX-103 missed both its primary and key secondary endpoints. Levi & Korsinsky is investigating potential securities law violations on behalf of TENX investors who suffered...Tenax Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Tenax Therapeutics (TENX)
Tenax Therapeutics shareholders were left holding a substantially lower-valued stock after the Phase 3 LEVEL readout for TNX-103 -- and those losses may carry legal rights. NEW YORK, Aug. 12, 2026 /PRNewswire/ -- A single disclosure erased approximately 84% to 85% of Tenax Therapeutics...Tenax LEVEL Trial Misses Primary Goal, but Subgroup Data Bolsters Levosimendan Case
Tenax Therapeutics (NASDAQ:TENX) reported that its Phase III LEVEL trial of oral levosimendan in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction, or PH-HFpEF, did not meet its primary endpoint, though the company said subgroup, biomarker and hemodyTenax Therapeutics, Inc. (TENX) Discusses Phase III LEVEL Trial Results for Oral Levosimendan in HFpEF Patients Transcript
Tenax Therapeutics, Inc. (TENX) Discusses Phase III LEVEL Trial Results for Oral Levosimendan in HFpEF Patients August 10, 2026 8:00 AM EDTCompany...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tenax Therapeutics
Sign Up For FreeTo access detailed company insights
Tenax Therapeutics Inc. is a specialty pharmaceutical company. It focuses on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical needs, with an initial therapeutic focus on pulmonary hypertension. The company was founded in 1967 and is based in Chapel Hill, North Carolina.... Read More
